SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Aphton (apht)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Volquardsen who wrote (87)3/31/1999 1:33:00 PM
From: mason630  Read Replies (1) of 95
 
I've been a shareholder since 94 with an average buy price of 17. It's good to see the price inching back up there. Aphton achieved another milestone today with their news release announcing "Clinical Proof of Concept in Prostate Cancer Patients. . . " That means their Gonadimmune (now called GnRH pharmaccine by SKB) works! I think this is exciting. I wonder when the Morgan Stanley Dean Witter brokers will get involved in the stock.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News